Clinical trials
Phase 1/2 Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Recruiting | 7 |
| Terminated | 6 |
| Unknown status | 6 |
| Withdrawn | 5 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Florida State University | 3 |
| University of Texas Southwestern Medical Center | 2 |
| Vanderbilt University Medical Center | 2 |
| ARKAY Therapeutics | 1 |
| Aga Khan University | 1 |
| Alnylam Pharmaceuticals | 1 |
| CRISPR Therapeutics AG | 1 |
| Capital Medical University | 1 |
| Cedars-Sinai Medical Center | 1 |
| Charite University, Berlin, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 50 |
| Cardiovascular Diseases | 7 |
| Diabetes Mellitus | 7 |
| Obesity | 7 |
| Metabolic Syndrome | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Hyperlipidemias | 3 |
| Inflammation | 3 |
| Overweight | 3 |
| Prehypertension | 3 |
Trials
Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.